Insider Buying: ASP Isotopes Inc. (NASDAQ:ASPI) Director Acquires 4,313 Shares of Stock

ASP Isotopes Inc. (NASDAQ:ASPI) Director Robert John Andrew Ryan acquired 4,313 shares of the stock in a transaction that occurred on Monday, April 29th. The shares were acquired at an average cost of $3.20 per share, with a total value of $13,801.60. Following the transaction, the director now owns 555,868 shares in the company, valued at $1,778,777.60. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Robert John Andrew Ryan also recently made the following trade(s):

• On Thursday, April 25th, Robert John Andrew Ryan bought 9,500 shares of ASP Isotopes stock. The stock was bought at an average price of $3.42 per share, with a total value of $32,490.00.

ASP Isotopes Stock Performance

ASPI stock opened at $3.16 on Thursday. The stock’s fifty day moving average is $3.73 and its two-hundred day moving average is $2.54. The stock has a market capitalization of $154.59 million, a price-to-earnings ratio of -6.45 and a beta of 5.03. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.85 and a current ratio of 1.85. ASP Isotopes Inc. has a 1 year low of $0.28 and a 1 year high of $4.97.

ASP Isotopes (NASDAQ:ASPI) last posted its earnings results on Wednesday, April 10th. The company reported ($0.09) earnings per share (EPS) for the quarter. The business had revenue of $0.43 million for the quarter. On average, research analysts predict that ASP Isotopes Inc. will post -0.11 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, HC Wainwright raised their price target on ASP Isotopes from $5.25 to $5.50 and gave the stock a “buy” rating in a report on Wednesday, April 17th.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in ASP Isotopes stock. Rathbones Group PLC bought a new position in ASP Isotopes Inc. (NASDAQ:ASPI) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 151,750 shares of the company’s stock, valued at approximately $272,000. Rathbones Group PLC owned 0.31% of ASP Isotopes as of its most recent SEC filing. Institutional investors and hedge funds own 16.80% of the company’s stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.